21st Annual NATA Symposium

21st Annual NATA Symposium, Athens 2020The 21st Annual NATA Symposium on Patient Blood Management, Haemostasis and Thrombosis will take place on April 23-24, 2020 in Athens, Greece.

Please click on the link below for more information
21st Annual Symposium General Information

Follow NATA on LinkedIn and Twitter

Join NATA's group on LinkedIn and follow NATA on Twitter (@NATAforum) to receive the latest news on patient blood management, haemostasis and thrombosis, and to participate in discussions with colleagues in the field.
LinkedIn Group / Twitter

News

Patient blood management in obstetrics: prevention and treatment of postpartum haemorrhage. A NATA consensus statement

Postpartum haemorrhage remains a common obstetric emergency and is the leading cause for maternal mortality worldwide.

The aim of this multidisciplinary consensus statement, published online ahead of print in Blood Transfusion on February 6, 2019, is to provide recommendations on the prevention and treatment of postpartum haemorrhage as part of patient blood management in obstetrics.

It was developed by NATA in collaboration with the International Federation of Gynaecology and Obstetrics (FIGO), the European Board and College of Obstetrics and Gynaecology (EBCOG) and the European Society of Anaesthesiology (ESA).

Read more on this

From the Literature

Jul 22, 2019

Published: Jun 2019

Spahn DR, Schoenrath F, Spahn GH, et al.

Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial.
Lancet 2019;393:2201-2212.

#

NATA REVIEW:
Preoperative anaemia detection and the timely management of deficiencies remain a serious challenge in many health...
REVIEW by:
B. Froessler

Published: May 2019

Vlot EA, Verwijmeren L, van de Garde EMW, Kloppenburg GTL, van Dongen EPA, Noordzij PG

Intra-operative red blood cell transfusion and mortality after cardiac surgery.
BMC Anesthesiol 2019;19:65.

#

NATA REVIEW:
Many studies have shown an association between transfusion and adverse events, including short- and long-term...
REVIEW by:
M. Pavesi

Published: May 2019

Althoff FC, Neb H, Herrmann E, et al.

Multimodal patient blood management program based on a three-pillar strategy: a systematic review and meta-analysis.
Ann Surg 2019;269:794-804.

#

NATA REVIEW:
This systematic review and meta-analysis focused on the implementation of a comprehensive PBM approach. Studies...
REVIEW by:
B. Froessler

Published: May 2019

Bhatt DL, Pollack CV, Weitz JI, et al.

Antibody-based ticagrelor reversal agent in healthy volunteers.
N Engl J Med 2019;308:1825-1833.

#

NATA REVIEW:
Dual antiplatelet therapy (DAPT) is frequently used in patients with acute coronary syndrome, coronary stents,...
REVIEW by:
D. Faraoni

Published: Apr 2019

Connolly SJ, Crowther M, Eikelboom JW, et al.

Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors.
N Engl J Med 2019;380:1326-1335.

#

NATA REVIEW:
Andexanet alfa, a recombinant inactive form of human factor Xa, was developed for reversal of factor Xa (FXa)...
REVIEW by:
J. H. Levy

Published: Feb 2019

Kuiper GJAJM, van Egmond LT, Henskens YMC, et al.

Shifts of transfusion demand in cardiac surgery after implementation of rotational thromboelastometry-guided transfusion protocols: analysis of the HEROES-CS observational, prospective open cohort database
J Cardiothorac Vasc Anesth 2019;33:307-317.

#

NATA REVIEW:
In this study, Kuiper et al. compared outcome after cardiac surgery in terms of bleeding, rethoracotomies,...
REVIEW by:
H. B. Ravn